Vitamin D metabolism in cancer: potential feasibility of vitamin D metabolism blocking therapy

Area of Science:

• Biochemistry
• Oncology
• Endocrinology

Background:

• Vitamin D plays a crucial role in cellular function; deficiency is linked to various pathologies, including cancer.
• Elevated expression of the enzyme CYP24A1 reduces vitamin D metabolite bioavailability.
• CYP24A1 is implicated in promoting carcinogenesis across multiple cancer subtypes.

Purpose of the Study:

• To review the potential of targeting the vitamin D metabolizing enzyme CYP24A1 as a therapeutic strategy.
• To explore the role of CYP24A1 in the development of breast, colorectal, and prostate tumors.
• To propose vitamin D metabolism-blocking therapy for malignancies expressing constitutive CYP24A1.

Main Methods:

• Literature review of studies on vitamin D metabolism and cancer.
• Analysis of data linking CYP24A1 expression to carcinogenesis.
• Evaluation of the feasibility of targeting CYP24A1 in human malignancies.

Main Results:

• Vitamin D deficiency impairs physiological functions, contributing to diseases like cancer.
• Increased CYP24A1 expression is associated with reduced vitamin D bioavailability and enhanced cancer development.
• CYP24A1 is constitutively expressed in various human tumors.

Conclusions:

• The enzyme CYP24A1 is a potential therapeutic target for various cancers.
• Therapies aimed at blocking vitamin D metabolism show promise for treating specific human malignancies.
• Targeting CYP24A1 could restore vitamin D's anti-cancer effects.